⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 26, 2004Antimicrobial Agents and ChemotherapyOpen Access

First Isolation of bla VIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Univ Bristol, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mendes et al. (2004) studied this question.

synapsesocial.com/papers/6a5bbfd219e8c79e69b9776f https://doi.org/10.1128/aac.48.4.1433-1434.2004

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a <i>Pseudomonas aeruginosa</i> Clinical Isolate in FranceOriginal Research · 2000 · 567 citations
2Metallo‐β‐Lactamases: A Class ApartOriginal Research · 1998 · 206 citations
3Cloning and Characterization of <i>bla</i> <sub>VIM</sub> , a New Integron-Borne Metallo-β-Lactamase Gene from a <i>Pseudomonas aeruginosa</i> Clinical IsolateOriginal Research · 1999 · 662 citations
4bla VIM-7 , an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United StatesOriginal Research · 2003 · 143 citations
5Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programmeOriginal Research · 2002 · 330 citations